Linden Thomas Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Linden Thomas Advisory Services’s Portfolio BMRN Stock Details BMRN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$695K	Buy
2024 Q2	–	Sell
2024 Q1	$1.56M	Buy
2023 Q4	$1.72M	Sell
2023 Q3	$1.6M	Sell
2023 Q2	$1.61M	Buy
2023 Q1	$1.8M	Buy
2022 Q4	$1.87M	Buy